ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Ankle Brachial Index Compared With Different Lipid Ratios to Predict Coronary Events in Patients with Coronary Artery Disease

Zinat Nadia Hatmi, Nassrin Jalilian, Ali Pakravan,Ahmad Sabouri Kashani.



Abstract
 Download PDF Post

AIM: Risk stratification in patients with angiographically confirmed coronary artery disease (CAD) could be made more precise. Since it is very difficult to determine which risk factors best predict clinical endpoints, a gentle design of risk stratification model with multiple risk factors may develop prognosis in CAD patients. There is no study with a high level of evidence including multiple risk factors to evaluate the prognostic role of different factors in acute coronary syndrome. This study aimed at determining the importance of different prognostic factors for clinical endpoints in CAD patients
METHODS: A prospective concurrent inception cohort study consisting of 521documented CAD patients 184 of whom were exposed participants who were angiographically documented CAD patients with ABI

Key words: Risk stratification, acute coronary syndrome, ankle brachial index, lipid measures, lipid ratios

Article Language: Turkish English

Bibliomed Article Statistics

22
20
17
25
25
34
37
34
20
29
23
5
R
E
A
D
S

9

6

10

11

11

10

13

22

10

12

9

1
D
O
W
N
L
O
A
D
S
070809101112010203040506
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Author Tools
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.